pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Preclinical
    APL-1501
    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B… Asieris Pharmaceuticals (USA) Inc
  • Phase 2
    APL-2302
    Breast Cancer Asieris Pharmaceuticals (USA) Inc
  • Phase 1
    APN-401
    Head And Neck Squamous Cell Carcinoma (HNSC) InvIOs GmbH
  • Phase 1
← prev
page 57 of 271
next →
Pain89
Neurology1
APNmAb-005
Alzheimer's Disease
Aprinoia Therapeutics Inc
  • Preclinical
    APP-13002
    Bacterial Conjunctivitis Formosa Pharmaceuticals Inc
  • Phase 2
    APPA-02
    Resistant Pseudomonas aeruginosa Infections$ARMP Armata Pharmaceuticals, Inc.
  • Phase 1
    APR-1051
    Breast Cancer$APRE Aprea Therapeutics, Inc.
  • Phase 2
    APS-03118
    Medullary Thyroid Cancer Applied Pharmaceutical Science Inc
  • Phase 2
    APSA-02
    Bacteremia$ARMP Armata Pharmaceuticals, Inc.
  • Preclinical
    APT-002
    Glioblastoma Multiforme (GBM) Aptah Bio Inc
  • Preclinical
    APT-101
    Idiopathic Pulmonary Fibrosis APIE Therapeutics Inc
  • Preclinical
    APT-110
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or… AptamiR Therapeutics Inc
  • Phase 2
    APTA-16
    Myelodysplastic Syndrome (Preleukemia) AptaBio Therapeutics Inc
  • Preclinical
    AQ-002
    Asthma Aquilon Pharmaceuticals SA
  • Preclinical
    AQ-003
    Chronic Obstructive Pulmonary Disease (COPD) Aquilon Pharmaceuticals SA
  • Preclinical
    AQ-004
    Lung Cancer Aquilon Pharmaceuticals SA
  • Phase 1
    AQ-280
    Eosinophilic Esophagitis Aqilion AB
  • Preclinical
    AR-170
    Solid Tumor Y-Biologics Inc
  • Preclinical
    ARB-1002
    Pancreatic Cancer Arbele Ltd
  • ARBLI
    ARBLI (LOSARTAN POTASSIUM)
    1 INDICATIONS AND USAGE Arbli is an angiotensin II recept…$SCNX Scienture Holdings, Inc.
  • Preclinical
    ARBM-201
    Acute Respiratory Distress Syndrome Arbormed Co Ltd
  • ARCALYST
    ARCALYST (RILONACEPT)
    no indication Kiniksa Pharmaceuticals Corp
  • Phase 2
    ARCT-032
    Cystic Fibrosis$ARCT Arcturus Therapeutics Holdings Inc.
  • Phase 2
    ARCT-165
    Coronavirus Disease 2019 (COVID-19) Seqirus Ltd
  • Phase 1
    ARCT-2304
    Influenza A Virus, H5N1 Subtype Infections$ARCT Arcturus Therapeutics Holdings Inc.
  • Phase 2
    ARCT-810
    Ornithine-Transcarbamylase Deficiency$ARCT Arcturus Therapeutics Holdings Inc.
  • Phase 2
    ARD-103
    Refractory Acute Myeloid Leukemia ARCE Therapeutics Inc
  • ARFORMOTEROL TARTRATE INHALATION
    ARFORMOTEROL TARTRATE INHALATION
    no indication SLATE RUN PHARMA
  • Preclinical
    ARG-006
    Hypoxic-Ischemic Encephalopathy Argenica Therapeutics Ltd
  • ARIKAYCE KIT
    ARIKAYCE KIT (AMIKACIN SULFATE)
    respiratory tract infectious disorder$INSM INSMED Inc